The 2018 Global Research Expedition on Altitude-related Chronic Health (REACH) to Cerro de Pasco, Peru: An Experimental Overview
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Experimental Physiology, Vol. 106, No. 1, 01.2021, p. 86-103.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - The 2018 Global Research Expedition on Altitude-related Chronic Health (REACH) to Cerro de Pasco, Peru: An Experimental Overview
AU - Tymko, Michael M
AU - Hoiland, Ryan L
AU - Tremblay, Joshua C
AU - Stembridge, Mike
AU - Dawkins, Tony G
AU - Coombs, Geoff B
AU - Patrician, Alexander
AU - Howe, Connor A
AU - Gibbons, Travis D
AU - Moore, Jonathan P
AU - Simpson, Lydia L
AU - Steinback, Craig D
AU - Meah, Victoria L
AU - Stacey, Benjamin S
AU - Bailey, Damian M
AU - MacLeod, David B
AU - Gasho, Christopher
AU - Anholm, James D
AU - Bain, Anthony R
AU - Lawley, Justin S
AU - Villafuerte, Francisco C
AU - Vizcardo-Galindo, Gustavo
AU - Ainslie, Philip N
N1 - Funding Information: Canada Research Chair; Natural Sciences and Engineering Research Council of Canada. Grant Number: Doctoral Grant ; Royal Society Wolfson Research Fellowship. Grant Number: #WM170007 Royal Society International Exchanges Award. Grant Number: IES\R2\192137 Japan Society for the Promotion of Science. Grant Number: Research Fellowship (#JSPS/OF317)
PY - 2021/1
Y1 - 2021/1
N2 - In 2016, the international research team ‐ Global Research Expedition on Altitude‐related Chronic Health (REACH) ‐ was established and executed a high altitude research expedition to Nepal. The team consists of ∼45 students, principal investigators and physicians with the common objective of conducting experiments focused on high altitude adaptation in lowlanders, and highlanders with lifelong exposure to high altitude. In 2018, Global REACH traveled to Peru where we performed a series of experiments in the Andean highlanders. The experimental objectives, organization and characteristics, and key cohort data from Global REACH's latest research expedition are outlined herein. Herein, fifteen major studies are described that aimed to elucidate the physiological differences in high altitude acclimatization between lowlanders (n = 30) and Andean born highlanders with (n = 22) and without (n = 45) Excessive Erythrocytosis (EE). After baseline testing in Kelowna, BC, Canada (344 m), Global REACH travelled to Lima, Peru (∼80 m), and then ascended by automobile to Cerro de Pasco, Peru (∼4300 m) where experiments were conducted over 25 days. The core studies focused on elucidating the mechanism(s) governing cerebral and peripheral vascular function, cardiopulmonary regulation, exercise performance, and autonomic control. Despite encountering serious logistical challenges, each of the proposed studies were completed at both sea level and high altitude amounting to ∼780 study sessions and > 3000 hrs of experimental testing. Participant demographics and data related to acid‐base balance and exercise capacity are presented. The collective findings will contribute to our understanding of how lowlanders and Andean highlanders have adapted under high altitude stress.
AB - In 2016, the international research team ‐ Global Research Expedition on Altitude‐related Chronic Health (REACH) ‐ was established and executed a high altitude research expedition to Nepal. The team consists of ∼45 students, principal investigators and physicians with the common objective of conducting experiments focused on high altitude adaptation in lowlanders, and highlanders with lifelong exposure to high altitude. In 2018, Global REACH traveled to Peru where we performed a series of experiments in the Andean highlanders. The experimental objectives, organization and characteristics, and key cohort data from Global REACH's latest research expedition are outlined herein. Herein, fifteen major studies are described that aimed to elucidate the physiological differences in high altitude acclimatization between lowlanders (n = 30) and Andean born highlanders with (n = 22) and without (n = 45) Excessive Erythrocytosis (EE). After baseline testing in Kelowna, BC, Canada (344 m), Global REACH travelled to Lima, Peru (∼80 m), and then ascended by automobile to Cerro de Pasco, Peru (∼4300 m) where experiments were conducted over 25 days. The core studies focused on elucidating the mechanism(s) governing cerebral and peripheral vascular function, cardiopulmonary regulation, exercise performance, and autonomic control. Despite encountering serious logistical challenges, each of the proposed studies were completed at both sea level and high altitude amounting to ∼780 study sessions and > 3000 hrs of experimental testing. Participant demographics and data related to acid‐base balance and exercise capacity are presented. The collective findings will contribute to our understanding of how lowlanders and Andean highlanders have adapted under high altitude stress.
KW - Adaptation, Physiological/physiology
KW - Adult
KW - Altitude
KW - Altitude Sickness/physiopathology
KW - Chronic Disease
KW - Cohort Studies
KW - Expeditions
KW - Heart/physiopathology
KW - Humans
KW - Hypoxia/physiopathology
KW - Male
KW - Peru
U2 - 10.1113/EP088350
DO - 10.1113/EP088350
M3 - Article
C2 - 32237245
VL - 106
SP - 86
EP - 103
JO - Experimental Physiology
JF - Experimental Physiology
SN - 0958-0670
IS - 1
ER -